Chemed (CHE) Long-Term Debt Issuances (2014 - 2026)

Chemed (CHE) posted quarterly Long-Term Debt Issuances of $135.5 million for Q1 2026, up 921.09% on a QoQ basis from -$16.5 million in Q4 2022.

Chemed (CHE) Long-Term Debt Issuances (2014 - 2026) Analysis & Trends

Chemed (CHE) has reported Long-Term Debt Issuances for 10 consecutive years, with $135.5 million the latest figure, recorded in Q1 2026.

In Q1 2026, Long-Term Debt Issuances changed N/A year-over-year to $135.5 million; the TTM figure through Mar 2026 stood at $214.0 million (changed N/A YoY), while the FY2022 annual figure was $100.0 million, down 52.45% from the prior year.
Long-Term Debt Issuances came in at $135.5 million for Q1 2026 at Chemed, up from -$16.5 million in the prior quarter.
The five-year high for Long-Term Debt Issuances was $135.5 million in Q1 2026, with the low at -$16.5 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	HCA Healthcare	87.94 Bn	90.32 Bn	16.26 Bn	-
2	Chemed	18.08 Bn	18.07 Bn	215.76 Mn	135.48 Mn
3	Tenet Healthcare	16.59 Bn	15.76 Bn	4.41 Bn	14.00 Mn
4	Davita	15.37 Bn	16.23 Bn	1.07 Bn	1.26 Bn
5	Encompass Health	10.07 Bn	10.70 Bn	1.34 Bn	250.00 Mn
6	Ensign	9.52 Bn	8.93 Bn	293.37 Mn	-
7	Universal Health Services	9.19 Bn	9.15 Bn	3.21 Bn	-
8	Pacs	6.96 Bn	6.72 Bn	345.96 Mn	-
9	Ww International	6.14 Bn	5.98 Bn	-149.29 Mn	-
10	Brookdale Senior Living	3.76 Bn	3.50 Bn	727.83 Mn	231.68 Mn

Download Data